Insider · CIK 0001761625

Weiss Lawrence Martin

Reports to the SEC for 1 company · FORT MYERS, FL

sec.gov

Transactions

Companies

Filings

CIK

0001761625

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-04-22	NEONEOGENOMICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,667 sh	$9.22	+$61.5K	112,464
2021-04-22	NEONEOGENOMICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,005 sh	$19.60	+$176K	121,469
2021-04-22	NEONEOGENOMICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,378 sh	$28.33	+$266K	130,847
2021-04-22	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,667 sh	—	—	0
2021-04-22	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,005 sh	—	—	18,012
2021-04-22	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,378 sh	—	—	28,136
2021-03-02	NEONEOGENOMICS INCA Award	Chief Medical Officer	AAward	+5,276 sh	—	—	105,797
2021-03-02	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+29.9K sh	$53.17	+$1.59M	29,895
2020-12-14	NEONEOGENOMICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+50K sh	$6.98	+$349K	61,717
2020-12-14	NEONEOGENOMICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+20K sh	$7.27	+$145K	81,717
2020-12-14	NEONEOGENOMICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+13.3K sh	$9.22	+$123K	95,050
2020-12-14	NEONEOGENOMICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+16.7K sh	$13.87	+$231K	111,716
2020-12-14	NEONEOGENOMICS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,005 sh	$19.60	+$176K	120,721
2020-12-14	NEONEOGENOMICS INCS Sale	Chief Medical Officer	SSale	−20.2K sh	$51.06	−$1.03M	100,521
2020-12-14	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−50K sh	—	—	0
2020-12-14	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−20K sh	—	—	0
2020-12-14	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−13.3K sh	—	—	6,667
2020-12-14	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−16.7K sh	—	—	8,334
2020-12-14	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,005 sh	—	—	27,017
2020-03-02	NEONEOGENOMICS INCA Award	Chief Medical Officer	AAward	+5,824 sh	—	—	11,717
2020-03-02	NEONEOGENOMICS INC · Common StockA Award	Chief Medical Officer	AAward	+37.5K sh	$28.33	+$1.06M	37,514
2019-03-01	NEONEOGENOMICS INCA Award	Chief Medical Officer	AAward	+5,893 sh	—	—	5,893
2019-03-01	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+36K sh	$19.60	+$706K	36,022
2018-12-12	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+25K sh	$13.87	+$347K	25,000

Recent filings

Accepted (ET)
Apr 264
Weiss Lawrence Martin0001077183-21-000113
SEC(opens sec.gov)
Mar 34
Weiss Lawrence Martin0001077183-21-000079
SEC(opens sec.gov)
Dec 154
Weiss Lawrence Martin0001077183-20-000227
SEC(opens sec.gov)
Mar 34
Weiss Lawrence Martin0001077183-20-000033
SEC(opens sec.gov)

Companies

NEOGENOMICS INCChief Medical OfficerNEO

Address

12701 COMMONWEALTH DRIVE SUITE 9

FORT MYERS, FL, 33913